ApiFix’s Minimally Invasive Deformity Correction (MID-C) System is a posterior dynamic deformity correction system device that enables surgeons to perform a novel surgical treatment providing permanent curve correction while retaining spine flexibility with a least invasive approach. The MID-C system has been used to treat more than 370 young patients diagnosed with progressive scoliosis with follow-up exceeding eight years. FDA approval via Humanitarian Device Exemption (HDE) was received in August 2019.

The unique ApiFix approach provides a viable alternative to failed bracing before considering spinal fusion for many patients as the least invasive spine deformity correction option. The MID-C system acts as an “internal brace” with motion-preserving polyaxial joints and a patented unidirectional, self-adjusting rod mechanism allowing additional post-operative correction over time and is ultimately removable.

The ApiFix device is implanted via a unilateral posterior procedure where patient recovery is relatively pain-free and is measured in days, not months – children are discharged from the hospital in 1-2 days and return to school in 1-2 weeks. The MID-C System has FDA and CE Mark approvals and is available in the USA, Canada, Europe, Israel and Singapore.